{"schema_version":"secwatch.filing_event.v1","accession":"0000926617-26-000037","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2026-05-26T13:03:51+00:00","discovered_at":"2026-05-26T13:05:00.234614+00:00","generated_at":"2026-05-26T13:06:01.515470+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.45,"confidence":"high","headline":"Aspira Women's Health enters collaboration with Cleveland Clinic for AI-powered diagnostics","bullets":["Partnering fee of $125,000; $50,000 due within 30 days, then $25,000 on each of first three anniversaries.","Collaboration focuses on biomarker discovery, AI-driven modeling, and clinical validation for women's health diagnostics.","Joint leadership: Dr. Kevin Elias (Cleveland Clinic) and Dr. Todd Pappas (Aspira) will lead multidisciplinary teams.","Initial five-year term; may be extended by mutual agreement; either party can terminate with 60 days' notice."],"urls":{"canonical":"https://secwatch.observer/filing/0000926617-26-000037","json":"https://secwatch.observer/filing/0000926617-26-000037.json","markdown":"https://secwatch.observer/filing/0000926617-26-000037.md","text":"https://secwatch.observer/filing/0000926617-26-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000092661726000037/0000926617-26-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000092661726000037/awhl-20260520x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T13:06:01.515470+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}